Hsbc Holdings PLC Bristol Myers Squibb CO Put Options Transaction History

Hsbc Holdings PLC

$160 Billion
Q2 2024

Put Options

23 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $1.94 Million - $2.31 Million	-40,000 Reduced 38.17%	64,800 $3.32 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $81,046 - $90,622	-1,400 Reduced 1.32%	104,800 $6.08 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $3.63 Million - $4.03 Million	-57,000 Reduced 34.93%	106,200 $6.79 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $12.5 Million - $14.1 Million	-189,700 Reduced 53.75%	163,200 $11.3 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $9.01 Million - $10.7 Million	131,600 Added 59.47%	352,900 $25.4 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $16 Million - $17.7 Million	220,800 Added 44160.0%	221,300 $17.1 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $1.23 Million - $1.44 Million	-23,000 Reduced 97.87%	500 $31,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $355,020 - $415,860	-6,000 Reduced 20.34%	23,500 $1.39 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $241,449 - $262,938	-3,900 Reduced 11.68%	29,500 $1.97 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $6.32 Million - $7.11 Million	-106,500 Reduced 76.13%	33,400 $2.11 Million
Q4 2020 Feb 25, 2021	BUY	$57.74 - $65.43 $5.72 Million - $6.48 Million	99,000 Added 242.05%	139,900 $8.68 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $3.93 Million - $4.36 Million	-68,500 Reduced 62.61%	40,900 $2.47 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $28.2 Million - $33 Million	-515,300 Reduced 82.49%	109,400 $6.43 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $5.35 Million - $7.78 Million	115,400 Added 22.66%	624,700 $34.9 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $28.3 Million - $37 Million	-575,700 Reduced 53.06%	509,300 $32.6 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $21.4 Million - $25.4 Million	500,100 Added 85.5%	1,085,000 $55 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $7.63 Million - $8.43 Million	170,900 Added 41.28%	584,900 $26.5 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $717,408 - $855,420	15,900 Added 3.99%	414,000 $19.8 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $2.54 Million - $3.29 Million	52,100 Added 15.06%	398,100 $20.7 Million
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $4.32 Million - $4.87 Million	78,200 Added 29.2%	346,000 $21.5 Million
Q2 2018 Aug 10, 2018	BUY	$50.53 - $62.98 $8.17 Million - $10.2 Million	161,700 Added 152.4%	267,800 $14.8 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $13.8 Million - $15.9 Million	-230,100 Reduced 68.44%	106,100 $6.71 Million
Q2 2017 Aug 14, 2017	BUY	N/A	336,200	336,200 $18.7 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account